Structure Therapeutics (GPCR) Earnings Date & Reports
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
GPCR is expected to report earnings to fall 24.32% to -28 cents per share on March 26
Q4'25
Est.
$-0.28
Q3'25
Missed
by $0.10
Q2'25
Missed
by $0.10
Q1'25
Missed
by $0.02
Q4'24
Beat
by $0.07
The last earnings report on November 06 showed earnings per share of -37 cents, missing the estimate of -27 cents. With 745.37K shares outstanding, the current market capitalization sits at 4.92B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GPCR showed earnings on November 06, 2025. You can read more about the earnings report here.